Most follicular lymphoma cases exhibit classic clinicopathologic ... Examples include BCL2-negative FL and CD10 or BCL6-negative FL. 1 Another variant with an unusual phenotype is FL with a ...

Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades. Yet up to 20% of patients develop early progression after starting ...

It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a partially follicular pattern. It is positive for the B-cell markers CD10, CD19 ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

New data from the Primary Rituximab And Maintenance study provide the strongest support for the use of rituximab maintenance in patients with follicular lymphoma. However, further considerations ...

NICE has said in first draft guidance that Roche's Gazyvaro (obinutuzumab) with bendamustine should not receive regular National Health Service funding for follicular lymphoma, a type of non ...